Leases (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of rent expense and sublease income

Rent expense is recognized over the expected term of the lease on a straight-line basis as a component of general and administrative expense. Rent expense and sublease income were as follows for the years ended December 31:


	2025		2024

Rent expense	$	1,580,113	$	1,384,083

Sublease income	$	667,814	$	554,069

Schedule of balance sheet classification

At December 31, 2025 and 2024, the Company recorded the following on the Consolidated Balance Sheet:


Right-of-Use Assets	December 31, 2025		December 31, 2024
Operating lease right-of-use assets	$	8,343,832	$	6,176,923


Lease Liabilities	December 31, 2025		December 31, 2024
Operating lease current liabilities	$	467,774	$	356,508
Operating lease non-current liabilities	4,471,965		4,939,739
Total	$	4,939,739	$	5,296,247

Schedule of operating lease liability maturities

Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are as follows:


Maturity of Leases Liabilities at December 31, 2025	Operating Leases
2026	$	909,911
2027	934,180
2028	740,791
2029	650,766
2030	667,049
After 2030	3,529,586
Total minimum lease payments	7,432,283
Less: Interest	(2,492,543)
Present value of lease liabilities	$	4,939,739

CUMBERLAND PHARMACEUTICALS INC 10-K